scandium has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Chakravarty, R; Goel, S; Hernandez, R; Hong, H; Nickles, RJ; Valdovinos, HF | 1 |
| Kasperek, K; Müller, W; Schicha, H; Schröder, R | 1 |
2 other study(ies) available for scandium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment.
Topics: Animals; Brain Neoplasms; Caco-2 Cells; Cetuximab; ErbB Receptors; Female; Flow Cytometry; Glioblastoma; Half-Life; Humans; Immunoglobulin Fab Fragments; Isotope Labeling; Mice, Nude; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Scandium; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
[Neutron activation analysis of the trace elements cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium in surgical specimens of human brain tumors. 1].
Topics: Activation Analysis; Antimony; Astrocytoma; Brain Chemistry; Brain Neoplasms; Cesium; Chromium; Cobalt; Ependymoma; Glioblastoma; Humans; Iron; Medulloblastoma; Meningioma; Neurilemmoma; Oligodendroglioma; Papilloma; Rubidium; Scandium; Selenium; Silver; Trace Elements; Zinc | 1974 |